Thelansis

Usher Syndrome Market Outlook Thelansis’s “Usher Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Usher Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What insights do in...

Usher Syndrome Market Outlook Thelansis’s “Usher Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Usher Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Usher Syndrome Overview Usher syndrome is a group of inherited disorders characterized by dual sensory impairment of the auditory and visual systems. It is the most common cause of combined sight and hearing loss, accounting for more than half of deaf-blindness cases. Nine causative genes have been identified and confirmed responsible for the syndrome when mutated, including MYO7A, USH1C, CDH23, PCDH15, and USH1G for Usher type 1; USH2A, ADGRV1, and WHRN for Ush...

  Usher syndrome is a group of inherited disorders characterized by dual sensory impairment of the auditory and visual systems. It is the most common cause of combined sight and hearing loss, accounting for more than half of deaf-blindness cases. Nine causative genes have been identified and confirmed responsible for the syndrome when mutated, including MYO7A, USH1C, CDH23, PCDH15, and USH1G for Usher type 1; USH2A, ADGRV1, and WHRN for Usher type 2; and CLRN1 for Usher type 3. Usher syndrome is clinically and genetically heterogeneous and is divided into three distinct clinical subtypes: Usher 1, Usher 2, and Usher 3. Usher 1 is the most severe subtype, in which patients exhibit severe to profound bilateral congenital sensorineural hearing loss, most frequently non-progressive, with vestibular areflexia. It accounts for approximately 25-44% of all Usher syndrome cases. Usher 2 represents over half of all cases. Sensorineural hearing loss is typically described as sloping, mild t...